Skip to main content
Top
Published in: Arthritis Research & Therapy 4/2008

Open Access 01-08-2008 | Research article

Fragmentation of decorin, biglycan, lumican and keratocan is elevated in degenerate human meniscus, knee and hip articular cartilages compared with age-matched macroscopically normal and control tissues

Authors: James Melrose, Emily S Fuller, Peter J Roughley, Margaret M Smith, Briedgeen Kerr, Clare E Hughes, Bruce Caterson, Christopher B Little

Published in: Arthritis Research & Therapy | Issue 4/2008

Login to get access

Abstract

Introduction

The small leucine-rich proteoglycans (SLRPs) modulate tissue organization, cellular proliferation, matrix adhesion, growth factor and cytokine responses, and sterically protect the surface of collagen type I and II fibrils from proteolysis. Catabolism of SLRPs has important consequences for the integrity of articular cartilage and meniscus by interfering with their tissue homeostatic functions.

Methods

SLRPs were dissociatively extracted from articular cartilage from total knee and hip replacements, menisci from total knee replacements, macroscopically normal and fibrillated knee articular cartilage from mature age-matched donors, and normal young articular cartilage. The tissue extracts were digested with chondroitinase ABC and keratanase-I before identification of SLRP core protein species by Western blotting using antibodies to the carboxyl-termini of the SLRPs.

Results

Multiple core-protein species were detected for all of the SLRPs (except fibromodulin) in the degenerate osteoarthritic articular cartilage and menisci. Fibromodulin had markedly less fragments detected with the carboxyl-terminal antibody compared with other SLRPs. There were fewer SLRP catabolites in osteoarthritic hip than in knee articular cartilage. Fragmentation of all SLRPs in normal age-matched, nonfibrillated knee articular cartilage was less than in fibrillated articular cartilage from the same knee joint or total knee replacement articular cartilage specimens of similar age. There was little fragmentation of SLRPs in normal control knee articular cartilage. Only decorin exhibited a consistent increase in fragmentation in menisci in association with osteoarthritis. There were no fragments of decorin, biglycan, lumican, or keratocan that were unique to any tissue. A single fibromodulin fragment was detected in osteoarthritic articular cartilage but not meniscus. All SLRPs showed a modest age-related increase in fragmentation in knee articular and meniscal cartilage but not in other tissues.

Conclusion

Enhanced fragmentation of SLRPs is evident in degenerate articular cartilage and meniscus. Specific decorin and fibromodulin core protein fragments in degenerate meniscus and/or human articular cartilage may be of value as biomarkers of disease. Once the enzymes responsible for their generation have been identified, further research may identify them as therapeutic targets.
Appendix
Available only for authorised users
Literature
1.
go back to reference Brooks PM: The burden of musculoskeletal disease: a global perspective. Clin Rheumatol. 2006, 25: 778-781. 10.1007/s10067-006-0240-3.CrossRefPubMed Brooks PM: The burden of musculoskeletal disease: a global perspective. Clin Rheumatol. 2006, 25: 778-781. 10.1007/s10067-006-0240-3.CrossRefPubMed
2.
go back to reference Gupta S, Hawker GA, Laporte A, Croxford R, Coyte PC: The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this condition. Rheumatology (Oxford). 2005, 44: 1531-1537. 10.1093/rheumatology/kei049.CrossRef Gupta S, Hawker GA, Laporte A, Croxford R, Coyte PC: The economic burden of disabling hip and knee osteoarthritis (OA) from the perspective of individuals living with this condition. Rheumatology (Oxford). 2005, 44: 1531-1537. 10.1093/rheumatology/kei049.CrossRef
3.
go back to reference Leardini G, Vaccaro E: Osteoarthritis: socioeconomic problems. Semin Arthritis Rheum. 2005, 34: 35-37. 10.1016/j.semarthrit.2004.03.010.CrossRefPubMed Leardini G, Vaccaro E: Osteoarthritis: socioeconomic problems. Semin Arthritis Rheum. 2005, 34: 35-37. 10.1016/j.semarthrit.2004.03.010.CrossRefPubMed
4.
go back to reference Rabenda V, Manette C, Lemmens R, Mariani AM, Struvay N, Reginster JY: Direct and indirect costs attributable to osteoarthritis in active subjects. J Rheumatol. 2006, 33: 1152-1158.PubMed Rabenda V, Manette C, Lemmens R, Mariani AM, Struvay N, Reginster JY: Direct and indirect costs attributable to osteoarthritis in active subjects. J Rheumatol. 2006, 33: 1152-1158.PubMed
5.
go back to reference Waal van der JM, Terwee CB, Windt van der DA, Bouter LM, Dekker J: Health-related and overall quality of life of patients with chronic hip and knee complaints in general practice. Qual Life Res. 2005, 14: 795-803. 10.1007/s11136-004-0801-3.CrossRefPubMed Waal van der JM, Terwee CB, Windt van der DA, Bouter LM, Dekker J: Health-related and overall quality of life of patients with chronic hip and knee complaints in general practice. Qual Life Res. 2005, 14: 795-803. 10.1007/s11136-004-0801-3.CrossRefPubMed
7.
go back to reference Flannery CR: Usurped SLRPs: novel arthritis biomarkers exposed by catabolism of small leucine-rich proteoglycans?. Arthritis Res Ther. 2006, 8: 106-10.1186/ar1925.PubMedCentralCrossRefPubMed Flannery CR: Usurped SLRPs: novel arthritis biomarkers exposed by catabolism of small leucine-rich proteoglycans?. Arthritis Res Ther. 2006, 8: 106-10.1186/ar1925.PubMedCentralCrossRefPubMed
8.
go back to reference Malemud CJ: Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci. 2006, 11: 1696-1701. 10.2741/1915.CrossRefPubMed Malemud CJ: Matrix metalloproteinases (MMPs) in health and disease: an overview. Front Biosci. 2006, 11: 1696-1701. 10.2741/1915.CrossRefPubMed
10.
go back to reference Thibault M, Poole AR, Buschmann MD: Cyclic compression of cartilage/bone explants in vitro leads to physical weakening, mechanical breakdown of collagen and release of matrix fragments. J Orthop Res. 2002, 20: 1265-1273. 10.1016/S0736-0266(02)00070-0.CrossRefPubMed Thibault M, Poole AR, Buschmann MD: Cyclic compression of cartilage/bone explants in vitro leads to physical weakening, mechanical breakdown of collagen and release of matrix fragments. J Orthop Res. 2002, 20: 1265-1273. 10.1016/S0736-0266(02)00070-0.CrossRefPubMed
11.
go back to reference Geng Y, McQuillan D, Roughley PJ: SLRP interaction can protect collagen fibrils from cleavage by collagenases. Matrix Biol. 2006, 25: 484-491. 10.1016/j.matbio.2006.08.259.CrossRefPubMed Geng Y, McQuillan D, Roughley PJ: SLRP interaction can protect collagen fibrils from cleavage by collagenases. Matrix Biol. 2006, 25: 484-491. 10.1016/j.matbio.2006.08.259.CrossRefPubMed
12.
go back to reference Iozzo RV: The biology of the small leucine rich repeat proteoglycans-funtional networks of interactive proteins. J Biol Chem. 1999, 274: 18843-18846. 10.1074/jbc.274.27.18843.CrossRefPubMed Iozzo RV: The biology of the small leucine rich repeat proteoglycans-funtional networks of interactive proteins. J Biol Chem. 1999, 274: 18843-18846. 10.1074/jbc.274.27.18843.CrossRefPubMed
13.
go back to reference Sztrolovics R, White RJ, Poole AR, Mort JS, Roughley PJ: Resistance of small leucine-rich repeat proteoglycans to proteolytic degradation during interleukin-1-stimulated cartilage catabolism. Biochem J. 1999, 339: 571-577. 10.1042/0264-6021:3390571.PubMedCentralCrossRefPubMed Sztrolovics R, White RJ, Poole AR, Mort JS, Roughley PJ: Resistance of small leucine-rich repeat proteoglycans to proteolytic degradation during interleukin-1-stimulated cartilage catabolism. Biochem J. 1999, 339: 571-577. 10.1042/0264-6021:3390571.PubMedCentralCrossRefPubMed
14.
go back to reference Liu CY, Birk DE, Hassell JR, Kane B, Kao WW: Keratocan-deficient mice display alterations in corneal structure. J Biol Chem. 2003, 278: 21672-21677. 10.1074/jbc.M301169200.CrossRefPubMed Liu CY, Birk DE, Hassell JR, Kane B, Kao WW: Keratocan-deficient mice display alterations in corneal structure. J Biol Chem. 2003, 278: 21672-21677. 10.1074/jbc.M301169200.CrossRefPubMed
15.
go back to reference Scott JE: Elasticity in extracellular matrix 'shape modules' of tendon, cartilage, etc. A sliding proteoglycan-filament model. J Physiol. 2003, 553: 335-343. 10.1113/jphysiol.2003.050179.PubMedCentralCrossRefPubMed Scott JE: Elasticity in extracellular matrix 'shape modules' of tendon, cartilage, etc. A sliding proteoglycan-filament model. J Physiol. 2003, 553: 335-343. 10.1113/jphysiol.2003.050179.PubMedCentralCrossRefPubMed
16.
go back to reference Scott JE, Stockwell RA: Cartilage elasticity resides in shape module decoran and aggrecan sumps of damping fluid: implications in osteoarthrosis. J Physiol. 2006, 574: 643-650. 10.1113/jphysiol.2006.108100.PubMedCentralCrossRefPubMed Scott JE, Stockwell RA: Cartilage elasticity resides in shape module decoran and aggrecan sumps of damping fluid: implications in osteoarthrosis. J Physiol. 2006, 574: 643-650. 10.1113/jphysiol.2006.108100.PubMedCentralCrossRefPubMed
17.
go back to reference McAlinden A, Dudhia J, Bolton MC, Lorenzo P, Heinegard D, Bayliss MT: Age-related changes in the synthesis and mRNA expression of decorin and aggrecan in human meniscus and articular cartilage. Osteoarthritis Cartilage. 2001, 9: 33-41. 10.1053/joca.2000.0347.CrossRefPubMed McAlinden A, Dudhia J, Bolton MC, Lorenzo P, Heinegard D, Bayliss MT: Age-related changes in the synthesis and mRNA expression of decorin and aggrecan in human meniscus and articular cartilage. Osteoarthritis Cartilage. 2001, 9: 33-41. 10.1053/joca.2000.0347.CrossRefPubMed
18.
go back to reference McDevitt CA, Webber RJ: The ultrastructure and biochemistry of meniscal cartilage. Clin Orthop Relat Res. 1990, 8-18. McDevitt CA, Webber RJ: The ultrastructure and biochemistry of meniscal cartilage. Clin Orthop Relat Res. 1990, 8-18.
19.
go back to reference Ghadially FN, Lalonde JM, Wedge JH: Ultrastructure of normal and torn menisci of the human knee joint. J Anat. 1983, 136: 773-791.PubMedCentralPubMed Ghadially FN, Lalonde JM, Wedge JH: Ultrastructure of normal and torn menisci of the human knee joint. J Anat. 1983, 136: 773-791.PubMedCentralPubMed
20.
go back to reference Hellio Le Graverand MP, Vignon E, Otterness IG, Hart DA: Early changes in lapine menisci during osteoarthritis development: part I: cellular and matrix alterations. Osteoarthritis Cartilage. 2001, 9: 56-64. 10.1053/joca.2000.0350.CrossRefPubMed Hellio Le Graverand MP, Vignon E, Otterness IG, Hart DA: Early changes in lapine menisci during osteoarthritis development: part I: cellular and matrix alterations. Osteoarthritis Cartilage. 2001, 9: 56-64. 10.1053/joca.2000.0350.CrossRefPubMed
21.
go back to reference Hough AJ, Webber RJ: Pathology of the meniscus. Clin Orthop Relat Res. 1990, 32-40. Hough AJ, Webber RJ: Pathology of the meniscus. Clin Orthop Relat Res. 1990, 32-40.
22.
go back to reference Noble J, Hamblen DL: The pathology of the degenerate meniscus lesion. J Bone Joint Surg Br. 1975, 57: 180-186.PubMed Noble J, Hamblen DL: The pathology of the degenerate meniscus lesion. J Bone Joint Surg Br. 1975, 57: 180-186.PubMed
23.
go back to reference Ameye L, Aria D, Jepsen K, Oldberg A, Xu T, Young MF: Abnormal collagen fibrils in tendons of biglycan/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis. FASEB J. 2002, 16: 673-680. 10.1096/fj.01-0848com.CrossRefPubMed Ameye L, Aria D, Jepsen K, Oldberg A, Xu T, Young MF: Abnormal collagen fibrils in tendons of biglycan/fibromodulin-deficient mice lead to gait impairment, ectopic ossification, and osteoarthritis. FASEB J. 2002, 16: 673-680. 10.1096/fj.01-0848com.CrossRefPubMed
24.
go back to reference Ameye L, Young MF: Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology. 2002, 12: 107R-116R. 10.1093/glycob/cwf065.CrossRefPubMed Ameye L, Young MF: Mice deficient in small leucine-rich proteoglycans: novel in vivo models for osteoporosis, osteoarthritis, Ehlers-Danlos syndrome, muscular dystrophy, and corneal diseases. Glycobiology. 2002, 12: 107R-116R. 10.1093/glycob/cwf065.CrossRefPubMed
25.
go back to reference Chakravarti S: Functions of lumican and fibromodulin: lessons from knockout mice. Glycoconj J. 2002, 19: 287-293. 10.1023/A:1025348417078.CrossRefPubMed Chakravarti S: Functions of lumican and fibromodulin: lessons from knockout mice. Glycoconj J. 2002, 19: 287-293. 10.1023/A:1025348417078.CrossRefPubMed
26.
go back to reference Chakravarti S, Paul J, Roberts L, Chervoneva I, Oldberg A, Birk DE: Ocular and scleral alterations in gene-targeted lumican-fibromodulin double-null mice. Invest Ophthalmol Vis Sci. 2003, 44: 2422-2432. 10.1167/iovs.02-0783.CrossRefPubMed Chakravarti S, Paul J, Roberts L, Chervoneva I, Oldberg A, Birk DE: Ocular and scleral alterations in gene-targeted lumican-fibromodulin double-null mice. Invest Ophthalmol Vis Sci. 2003, 44: 2422-2432. 10.1167/iovs.02-0783.CrossRefPubMed
27.
go back to reference Corsi A, Xu T, Chen XD, Boyde A, Liang J, Mankani M, Sommer B, Iozzo RV, Eichstetter I, Robey PG, Bianco P, Young MF: Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J Bone Miner Res. 2002, 17: 1180-1189. 10.1359/jbmr.2002.17.7.1180.CrossRefPubMed Corsi A, Xu T, Chen XD, Boyde A, Liang J, Mankani M, Sommer B, Iozzo RV, Eichstetter I, Robey PG, Bianco P, Young MF: Phenotypic effects of biglycan deficiency are linked to collagen fibril abnormalities, are synergized by decorin deficiency, and mimic Ehlers-Danlos-like changes in bone and other connective tissues. J Bone Miner Res. 2002, 17: 1180-1189. 10.1359/jbmr.2002.17.7.1180.CrossRefPubMed
28.
go back to reference Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV: Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol. 1997, 136: 729-743. 10.1083/jcb.136.3.729.PubMedCentralCrossRefPubMed Danielson KG, Baribault H, Holmes DF, Graham H, Kadler KE, Iozzo RV: Targeted disruption of decorin leads to abnormal collagen fibril morphology and skin fragility. J Cell Biol. 1997, 136: 729-743. 10.1083/jcb.136.3.729.PubMedCentralCrossRefPubMed
29.
go back to reference Ezura Y, Chakravarti S, Oldberg A, Chervoneva I, Birk DE: Differential expression of lumican and fibromodulin regulate collagen fibrillogenesis in developing mouse tendons. J Cell Biol. 2000, 151: 779-788. 10.1083/jcb.151.4.779.PubMedCentralCrossRefPubMed Ezura Y, Chakravarti S, Oldberg A, Chervoneva I, Birk DE: Differential expression of lumican and fibromodulin regulate collagen fibrillogenesis in developing mouse tendons. J Cell Biol. 2000, 151: 779-788. 10.1083/jcb.151.4.779.PubMedCentralCrossRefPubMed
30.
go back to reference Jepsen KJ, Wu F, Peragallo JH, Paul J, Roberts L, Ezura Y, Oldberg A, Birk DE, Chakravarti S: A syndrome of joint laxity and impaired tendon integrity in lumican- and fibromodulin-deficient mice. J Biol Chem. 2002, 277: 35532-35540. 10.1074/jbc.M205398200.CrossRefPubMed Jepsen KJ, Wu F, Peragallo JH, Paul J, Roberts L, Ezura Y, Oldberg A, Birk DE, Chakravarti S: A syndrome of joint laxity and impaired tendon integrity in lumican- and fibromodulin-deficient mice. J Biol Chem. 2002, 277: 35532-35540. 10.1074/jbc.M205398200.CrossRefPubMed
31.
go back to reference Robinson PS, Huang TF, Kazam E, Iozzo RV, Birk DE, Soslowsky LJ: Influence of decorin and biglycan on mechanical properties of multiple tendons in knockout mice. J Biomech Eng. 2005, 127: 181-185. 10.1115/1.1835363.CrossRefPubMed Robinson PS, Huang TF, Kazam E, Iozzo RV, Birk DE, Soslowsky LJ: Influence of decorin and biglycan on mechanical properties of multiple tendons in knockout mice. J Biomech Eng. 2005, 127: 181-185. 10.1115/1.1835363.CrossRefPubMed
32.
go back to reference Svensson L, Aszodi A, Reinholt FP, Fassler R, Heinegard D, Oldberg A: Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon. J Biol Chem. 1999, 274: 9636-9647. 10.1074/jbc.274.14.9636.CrossRefPubMed Svensson L, Aszodi A, Reinholt FP, Fassler R, Heinegard D, Oldberg A: Fibromodulin-null mice have abnormal collagen fibrils, tissue organization, and altered lumican deposition in tendon. J Biol Chem. 1999, 274: 9636-9647. 10.1074/jbc.274.14.9636.CrossRefPubMed
33.
go back to reference Wadhwa S, Embree M, Ameye L, Young MF: Mice deficient in biglycan and fibromodulin as a model for temporomandibular joint osteoarthritis. Cells Tissues Organs. 2005, 181: 136-143. 10.1159/000091375.CrossRefPubMed Wadhwa S, Embree M, Ameye L, Young MF: Mice deficient in biglycan and fibromodulin as a model for temporomandibular joint osteoarthritis. Cells Tissues Organs. 2005, 181: 136-143. 10.1159/000091375.CrossRefPubMed
34.
go back to reference Wadhwa S, Embree MC, Kilts T, Young MF, Ameye LG: Accelerated osteoarthritis in the temporomandibular joint of biglycan/fibromodulin double-deficient mice. Osteoarthritis Cartilage. 2005, 13: 817-827. 10.1016/j.joca.2005.04.016.CrossRefPubMed Wadhwa S, Embree MC, Kilts T, Young MF, Ameye LG: Accelerated osteoarthritis in the temporomandibular joint of biglycan/fibromodulin double-deficient mice. Osteoarthritis Cartilage. 2005, 13: 817-827. 10.1016/j.joca.2005.04.016.CrossRefPubMed
35.
go back to reference Young MF, Bi Y, Ameye L, Chen XD: Biglycan knockout mice: new models for musculoskeletal diseases. Glycoconj J. 2002, 19: 257-262. 10.1023/A:1025336114352.CrossRefPubMed Young MF, Bi Y, Ameye L, Chen XD: Biglycan knockout mice: new models for musculoskeletal diseases. Glycoconj J. 2002, 19: 257-262. 10.1023/A:1025336114352.CrossRefPubMed
36.
go back to reference Melrose J, Smith SM, Fuller ES, Young AA, Roughley PJ, Dart A, Little CB: Biglycan and fibromodulin fragmentation correlates with temporal and spatial annular remodelling in experimentally injured ovine intervertebral discs. Eur Spine J. 2007, 16: 2193-2205. 10.1007/s00586-007-0497-5.PubMedCentralCrossRefPubMed Melrose J, Smith SM, Fuller ES, Young AA, Roughley PJ, Dart A, Little CB: Biglycan and fibromodulin fragmentation correlates with temporal and spatial annular remodelling in experimentally injured ovine intervertebral discs. Eur Spine J. 2007, 16: 2193-2205. 10.1007/s00586-007-0497-5.PubMedCentralCrossRefPubMed
37.
go back to reference Roughley PJ: The structure and function of cartilage proteoglycans. Eur Cell Mater. 2006, 12: 92-101.PubMed Roughley PJ: The structure and function of cartilage proteoglycans. Eur Cell Mater. 2006, 12: 92-101.PubMed
38.
go back to reference Heathfield TF, Onnerfjord P, Dahlberg L, Heinegard D: Cleavage of fibromodulin in cartilage explants involves removal of the N-terminal tyrosine sulfate-rich region by proteolysis at a site that is sensitive to matrix metalloproteinase-13. J Biol Chem. 2004, 279: 6286-6295. 10.1074/jbc.M307765200.CrossRefPubMed Heathfield TF, Onnerfjord P, Dahlberg L, Heinegard D: Cleavage of fibromodulin in cartilage explants involves removal of the N-terminal tyrosine sulfate-rich region by proteolysis at a site that is sensitive to matrix metalloproteinase-13. J Biol Chem. 2004, 279: 6286-6295. 10.1074/jbc.M307765200.CrossRefPubMed
39.
go back to reference Imai K, Hiramatsu A, Fukushima D, Pierschbacher MD, Okada Y: Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem J. 1997, 322: 809-814.PubMedCentralCrossRefPubMed Imai K, Hiramatsu A, Fukushima D, Pierschbacher MD, Okada Y: Degradation of decorin by matrix metalloproteinases: identification of the cleavage sites, kinetic analyses and transforming growth factor-beta1 release. Biochem J. 1997, 322: 809-814.PubMedCentralCrossRefPubMed
40.
go back to reference Melching LI, Fisher WD, Lee ER, Mort JS, Roughley PJ: The cleavage of biglycan by aggrecanases. Osteoarthritis Cartilage. 2006, 14: 1147-1154. 10.1016/j.joca.2006.05.014.CrossRefPubMed Melching LI, Fisher WD, Lee ER, Mort JS, Roughley PJ: The cleavage of biglycan by aggrecanases. Osteoarthritis Cartilage. 2006, 14: 1147-1154. 10.1016/j.joca.2006.05.014.CrossRefPubMed
41.
go back to reference Monfort J, Tardif G, Reboul P, Mineau F, Roughley P, Pelletier JP, Martel-Pelletier J: Degradation of small leucine-rich repeat proteoglycans by matrix metalloprotease-13: identification of a new biglycan cleavage site. Arthritis Res Ther. 2006, 8: R26-10.1186/ar1873.PubMedCentralCrossRefPubMed Monfort J, Tardif G, Reboul P, Mineau F, Roughley P, Pelletier JP, Martel-Pelletier J: Degradation of small leucine-rich repeat proteoglycans by matrix metalloprotease-13: identification of a new biglycan cleavage site. Arthritis Res Ther. 2006, 8: R26-10.1186/ar1873.PubMedCentralCrossRefPubMed
42.
go back to reference Kashiwagi M, Enghild JJ, Gendron C, Hughes C, Caterson B, Itoh Y, Nagase H: Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing. J Biol Chem. 2004, 279: 10109-10119. 10.1074/jbc.M312123200.CrossRefPubMed Kashiwagi M, Enghild JJ, Gendron C, Hughes C, Caterson B, Itoh Y, Nagase H: Altered proteolytic activities of ADAMTS-4 expressed by C-terminal processing. J Biol Chem. 2004, 279: 10109-10119. 10.1074/jbc.M312123200.CrossRefPubMed
43.
go back to reference Roughley PJ, Lee ER: Cartilage proteoglycans: structure and potential functions. Microsc Res Tech. 1994, 28: 385-397. 10.1002/jemt.1070280505.CrossRefPubMed Roughley PJ, Lee ER: Cartilage proteoglycans: structure and potential functions. Microsc Res Tech. 1994, 28: 385-397. 10.1002/jemt.1070280505.CrossRefPubMed
44.
go back to reference Roughley PJ, Melching LI, Recklies AD: Changes in the expression of decorin and biglycan in human articular cartilage with age and regulation by TGF-beta. Matrix Biol. 1994, 14: 51-59. 10.1016/0945-053X(94)90029-9.CrossRefPubMed Roughley PJ, Melching LI, Recklies AD: Changes in the expression of decorin and biglycan in human articular cartilage with age and regulation by TGF-beta. Matrix Biol. 1994, 14: 51-59. 10.1016/0945-053X(94)90029-9.CrossRefPubMed
45.
go back to reference Roughley PJ, White RJ, Magny MC, Liu J, Pearce RH, Mort JS: Non-proteoglycan forms of biglycan increase with age in human articular cartilage. Biochem J. 1993, 295: 421-426.PubMedCentralCrossRefPubMed Roughley PJ, White RJ, Magny MC, Liu J, Pearce RH, Mort JS: Non-proteoglycan forms of biglycan increase with age in human articular cartilage. Biochem J. 1993, 295: 421-426.PubMedCentralCrossRefPubMed
47.
go back to reference Roughley PJ, White RJ, Cs-Szabo G, Mort JS: Changes with age in the structure of fibromodulin in human articular cartilage. Osteoarthritis Cartilage. 1996, 4: 153-161. 10.1016/S1063-4584(96)80011-2.CrossRefPubMed Roughley PJ, White RJ, Cs-Szabo G, Mort JS: Changes with age in the structure of fibromodulin in human articular cartilage. Osteoarthritis Cartilage. 1996, 4: 153-161. 10.1016/S1063-4584(96)80011-2.CrossRefPubMed
48.
go back to reference Alini M, Roughley PJ: Changes in leucine-rich repeat proteoglycans during maturation of the bovine growth plate. Matrix Biol. 2001, 19: 805-813. 10.1016/S0945-053X(00)00129-3.CrossRefPubMed Alini M, Roughley PJ: Changes in leucine-rich repeat proteoglycans during maturation of the bovine growth plate. Matrix Biol. 2001, 19: 805-813. 10.1016/S0945-053X(00)00129-3.CrossRefPubMed
49.
go back to reference Melching LI, Roughley PJ: Modulation of keratan sulfate synthesis on lumican by the action of cytokines on human articular chondrocytes. Matrix Biol. 1999, 18: 381-390. 10.1016/S0945-053X(99)00033-5.CrossRefPubMed Melching LI, Roughley PJ: Modulation of keratan sulfate synthesis on lumican by the action of cytokines on human articular chondrocytes. Matrix Biol. 1999, 18: 381-390. 10.1016/S0945-053X(99)00033-5.CrossRefPubMed
50.
go back to reference Sztrolovics R, Alini M, Mort JS, Roughley PJ: Age-related changes in fibromodulin and lumican in human intervertebral discs. Spine. 1999, 24: 1765-1771. 10.1097/00007632-199909010-00003.CrossRefPubMed Sztrolovics R, Alini M, Mort JS, Roughley PJ: Age-related changes in fibromodulin and lumican in human intervertebral discs. Spine. 1999, 24: 1765-1771. 10.1097/00007632-199909010-00003.CrossRefPubMed
51.
go back to reference Johnstone B, Markopoulos M, Neame P, Caterson B: Identification and characterization of glycanated and non-glycanated forms of biglycan and decorin in the human intervertebral disc. Biochem J. 1993, 292: 661-666.PubMedCentralCrossRefPubMed Johnstone B, Markopoulos M, Neame P, Caterson B: Identification and characterization of glycanated and non-glycanated forms of biglycan and decorin in the human intervertebral disc. Biochem J. 1993, 292: 661-666.PubMedCentralCrossRefPubMed
52.
go back to reference Lauder RM, Huckerby TN, Nieduszynski IA, Plaas AH: Age-related changes in the structure of the keratan sulphate chains attached to fibromodulin isolated from articular cartilage. Biochem J. 1998, 330: 753-757.PubMedCentralCrossRefPubMed Lauder RM, Huckerby TN, Nieduszynski IA, Plaas AH: Age-related changes in the structure of the keratan sulphate chains attached to fibromodulin isolated from articular cartilage. Biochem J. 1998, 330: 753-757.PubMedCentralCrossRefPubMed
53.
go back to reference Carrino DA, Onnerfjord P, Sandy JD, Cs-Szabo G, Scott PG, Sorrell JM, Heinegard D, Caplan AI: Age-related changes in the proteoglycans of human skin. Specific cleavage of decorin to yield a major catabolic fragment in adult skin. J Biol Chem. 2003, 278: 17566-17572. 10.1074/jbc.M300124200.CrossRefPubMed Carrino DA, Onnerfjord P, Sandy JD, Cs-Szabo G, Scott PG, Sorrell JM, Heinegard D, Caplan AI: Age-related changes in the proteoglycans of human skin. Specific cleavage of decorin to yield a major catabolic fragment in adult skin. J Biol Chem. 2003, 278: 17566-17572. 10.1074/jbc.M300124200.CrossRefPubMed
54.
go back to reference Cs-Szabo G, Melching LI, Roughley PJ, Glant TT: Changes in messenger RNA and protein levels of proteoglycans and link protein in human osteoarthritic cartilage samples. Arthritis Rheum. 1997, 40: 1037-1045. 10.1002/art.1780400607.CrossRefPubMed Cs-Szabo G, Melching LI, Roughley PJ, Glant TT: Changes in messenger RNA and protein levels of proteoglycans and link protein in human osteoarthritic cartilage samples. Arthritis Rheum. 1997, 40: 1037-1045. 10.1002/art.1780400607.CrossRefPubMed
55.
go back to reference Cs-Szabo G, Roughley PJ, Plaas AH, Glant TT: Large and small proteoglycans of osteoarthritic and rheumatoid articular cartilage. Arthritis Rheum. 1995, 38: 660-668. 10.1002/art.1780380514.CrossRefPubMed Cs-Szabo G, Roughley PJ, Plaas AH, Glant TT: Large and small proteoglycans of osteoarthritic and rheumatoid articular cartilage. Arthritis Rheum. 1995, 38: 660-668. 10.1002/art.1780380514.CrossRefPubMed
56.
go back to reference Witsch-Prehm P, Miehlke R, Kresse H: Presence of small proteoglycan fragments in normal and arthritic human cartilage. Arthritis Rheum. 1992, 35: 1042-1052. 10.1002/art.1780350909.CrossRefPubMed Witsch-Prehm P, Miehlke R, Kresse H: Presence of small proteoglycan fragments in normal and arthritic human cartilage. Arthritis Rheum. 1992, 35: 1042-1052. 10.1002/art.1780350909.CrossRefPubMed
57.
go back to reference Gealy EC, Kerr BC, Young RD, Tudor D, Hayes AJ, Hughes CE, Caterson B, Quantock AJ, Ralphs JR: Differential expression of the keratan sulphate proteoglycan, keratocan, during chick corneal embryogenesis. Histochem Cell Biol. 2007, 128: 551-555. 10.1007/s00418-007-0332-4.CrossRefPubMed Gealy EC, Kerr BC, Young RD, Tudor D, Hayes AJ, Hughes CE, Caterson B, Quantock AJ, Ralphs JR: Differential expression of the keratan sulphate proteoglycan, keratocan, during chick corneal embryogenesis. Histochem Cell Biol. 2007, 128: 551-555. 10.1007/s00418-007-0332-4.CrossRefPubMed
58.
59.
go back to reference Fujita Y, Hara Y, Nezu Y, Yamaguchi S, Schulz KS, Tagawa M: Direct and indirect markers of cartilage metabolism in synovial fluid obtained from dogs with hip dysplasia and correlation with clinical and radiographic variables. Am J Vet Res. 2005, 66: 2028-2033. 10.2460/ajvr.2005.66.2028.CrossRefPubMed Fujita Y, Hara Y, Nezu Y, Yamaguchi S, Schulz KS, Tagawa M: Direct and indirect markers of cartilage metabolism in synovial fluid obtained from dogs with hip dysplasia and correlation with clinical and radiographic variables. Am J Vet Res. 2005, 66: 2028-2033. 10.2460/ajvr.2005.66.2028.CrossRefPubMed
60.
go back to reference Garnero P: Use of biochemical markers to study and follow patients with osteoarthritis. Curr Rheumatol Rep. 2006, 8: 37-44. 10.1007/s11926-006-0023-5.CrossRefPubMed Garnero P: Use of biochemical markers to study and follow patients with osteoarthritis. Curr Rheumatol Rep. 2006, 8: 37-44. 10.1007/s11926-006-0023-5.CrossRefPubMed
61.
go back to reference Huebner JL, Kraus VB: Assessment of the utility of biomarkers of osteoarthritis in the guinea pig. Osteoarthritis Cartilage. 2006, 14: 923-930. 10.1016/j.joca.2006.03.007.CrossRefPubMed Huebner JL, Kraus VB: Assessment of the utility of biomarkers of osteoarthritis in the guinea pig. Osteoarthritis Cartilage. 2006, 14: 923-930. 10.1016/j.joca.2006.03.007.CrossRefPubMed
62.
go back to reference Matyas JR, Atley L, Ionescu M, Eyre DR, Poole AR: Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis. Arthritis Rheum. 2004, 50: 543-552. 10.1002/art.20027.CrossRefPubMed Matyas JR, Atley L, Ionescu M, Eyre DR, Poole AR: Analysis of cartilage biomarkers in the early phases of canine experimental osteoarthritis. Arthritis Rheum. 2004, 50: 543-552. 10.1002/art.20027.CrossRefPubMed
63.
go back to reference Mazieres B, Garnero P, Gueguen A, Abbal M, Berdah L, Lequesne M, Nguyen M, Salles JP, Vignon E, Dougados M: Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort. Ann Rheum Dis. 2006, 65: 354-359. 10.1136/ard.2005.037275.PubMedCentralCrossRefPubMed Mazieres B, Garnero P, Gueguen A, Abbal M, Berdah L, Lequesne M, Nguyen M, Salles JP, Vignon E, Dougados M: Molecular markers of cartilage breakdown and synovitis at baseline as predictors of structural progression of hip osteoarthritis. The ECHODIAH Cohort. Ann Rheum Dis. 2006, 65: 354-359. 10.1136/ard.2005.037275.PubMedCentralCrossRefPubMed
64.
go back to reference Na KS, Kim TH, Inman RD: Biomarkers in spondyloarthritis. Curr Rheumatol Rep. 2006, 8: 283-286. 10.1007/s11926-006-0009-3.CrossRefPubMed Na KS, Kim TH, Inman RD: Biomarkers in spondyloarthritis. Curr Rheumatol Rep. 2006, 8: 283-286. 10.1007/s11926-006-0009-3.CrossRefPubMed
65.
go back to reference Poole AR: Biologic markers and disc degeneration. J Bone Joint Surg Am. 2006, 88 (suppl 2): 72-75. 10.2106/JBJS.E.01326.CrossRefPubMed Poole AR: Biologic markers and disc degeneration. J Bone Joint Surg Am. 2006, 88 (suppl 2): 72-75. 10.2106/JBJS.E.01326.CrossRefPubMed
66.
go back to reference Schaller S, Henriksen K, Hoegh-Andersen P, Sondergaard BC, Sumer EU, Tanko LB, Qvist P, Karsdal MA: In vitro, ex vivo, and in vivo methodological approaches for studying therapeutic targets of osteoporosis and degenerative joint diseases: how biomarkers can assist?. Assay Drug Dev Technol. 2005, 3: 553-580. 10.1089/adt.2005.3.553.CrossRefPubMed Schaller S, Henriksen K, Hoegh-Andersen P, Sondergaard BC, Sumer EU, Tanko LB, Qvist P, Karsdal MA: In vitro, ex vivo, and in vivo methodological approaches for studying therapeutic targets of osteoporosis and degenerative joint diseases: how biomarkers can assist?. Assay Drug Dev Technol. 2005, 3: 553-580. 10.1089/adt.2005.3.553.CrossRefPubMed
67.
go back to reference Sharif M, Granell R, Johansen J, Clarke S, Elson C, Kirwan JR: Serum cartilage oligomeric matrix protein and other biomarker profiles in tibiofemoral and patellofemoral osteoarthritis of the knee. Rheumatology (Oxford). 2006, 45: 522-526. 10.1093/rheumatology/kei216.CrossRef Sharif M, Granell R, Johansen J, Clarke S, Elson C, Kirwan JR: Serum cartilage oligomeric matrix protein and other biomarker profiles in tibiofemoral and patellofemoral osteoarthritis of the knee. Rheumatology (Oxford). 2006, 45: 522-526. 10.1093/rheumatology/kei216.CrossRef
Metadata
Title
Fragmentation of decorin, biglycan, lumican and keratocan is elevated in degenerate human meniscus, knee and hip articular cartilages compared with age-matched macroscopically normal and control tissues
Authors
James Melrose
Emily S Fuller
Peter J Roughley
Margaret M Smith
Briedgeen Kerr
Clare E Hughes
Bruce Caterson
Christopher B Little
Publication date
01-08-2008
Publisher
BioMed Central
Published in
Arthritis Research & Therapy / Issue 4/2008
Electronic ISSN: 1478-6362
DOI
https://doi.org/10.1186/ar2453

Other articles of this Issue 4/2008

Arthritis Research & Therapy 4/2008 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.